I agree that this site is using cookies. You can find further informations here.
X
Schuch, Raymond
202  results:
Search for persons X
?
1

Exebacase in Addition to Standard-of-Care Antibiotics for S..:

Fowler Jr, Vance G ; Das, Anita F ; Lipka-Diamond, Joy...
Clinical Infectious Diseases.  78 (2024)  6 - p. 1473-1481 , 2024
Link: https://doi.org/10.1093/..
 
?
2

The Engineered Lysin CF-370 Is Active Against Antibiotic-Re..:

Sauve, Karen ; Watson, Aubrey ; Oh, Jun T...
The Journal of Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
3

In vitro activity of exebacase against methicillin-resistan..:

Karau, Melissa J. ; Mandrekar, Jay ; Lehoux, Dario...
BMC Research Notes.  16 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Rapid bacteriolysis ofStaphylococcus aureusby lysin exebaca..:

Vila-Farres, Xavier ; Sauve, Karen ; Oh, Jun...
Microbiology Spectrum.  11 (2023)  5 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
5

The Lysin Exebacase Has a Low Propensity for Resistance Dev..:

Oh, Jun ; Warner, Matthew ; Ambler, Jane E...
Microbiology Spectrum.  11 (2023)  2 - p. , 2023
Link: https://doi.org/10.1128/..
 
?
6

Activity of Exebacase (CF-301) against Biofilms Formed by S..:

Souche, Aubin ; Kolenda, Camille ; Teoli, Jordan...
Antimicrobial Agents and Chemotherapy.  66 (2022)  8 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
7

Locally delivered antistaphylococcal lysin exebacase or CF-..:

Karau, Melissa ; Schmidt-Malan, Suzannah ; Mandrekar, Jay...
Journal of Bone and Joint Infection.  7 (2022)  4 - p. 169-175 , 2022
Link: https://doi.org/10.5194/..
 
?
8

Direct Lytic Agents: Novel, Rapidly Acting Potential Antimi..:

Schuch, Raymond ; Cassino, Cara ; Vila-Farres, Xavier
Frontiers in Microbiology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
9

Determination of MIC Quality Control Parameters for Exebaca..:

Traczewski, Maria M. ; Ambler, Jane E. ; Schuch, Raymond.
Journal of Clinical Microbiology.  59 (2021)  7 - p. , 2021
Link: https://doi.org/10.1128/..
 
?
10

Development of a Broth Microdilution Method for Exebacase S..:

Oh, Jun T. ; Ambler, Jane E. ; Cassino, Cara.
Antimicrobial Agents and Chemotherapy.  65 (2021)  7 - p. , 2021
Link: https://doi.org/10.1128/..
 
?
11

Efficacy assessment of lysin CF-296 in addition to daptomyc..:

Asempa, Tomefa E ; DeRosa, Nicole A ; Cassino, Cara...
Journal of Antimicrobial Chemotherapy.  76 (2021)  10 - p. 2622-2628 , 2021
Link: https://doi.org/10.1093/..
 
?
12

Exebacase Is ActiveIn Vitroin Pulmonary Surfactant and Is E..:

Swift, Steven M. ; Sauve, Karen ; Cassino, Cara.
Antimicrobial Agents and Chemotherapy.  65 (2021)  9 - p. , 2021
Link: https://doi.org/10.1128/..
 
?
13

1264. Assessment of In Vivo Efficacy of CF-296 in addition ..:

Asempa, Tomefa E ; DeRosa, Nicole A ; Cassino, Cara...
Open Forum Infectious Diseases.  7 (2020)  Supplement_1 - p. S648-S649 , 2020
Link: https://doi.org/10.1093/..
 
?
14

671. Impact of Dose-Administration Strategies of the Antist..:

Xiong, Yan ; Abdelhady, Wessam ; Li, Liang...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S307-S307 , 2019
Link: https://doi.org/10.1093/..
 
?
15

712. Activity of Exebacase (CF-301) Against Methicillin-Res..:

Karau, Melissa J ; Schmidt-Malan, Suzannah ; Mandrekar, Jayawant...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S320-S320 , 2019
Link: https://doi.org/10.1093/..
 
1-15